The feasibility, safety, and efficacy of Paxlovid treatment in SARS-CoV-2-infected children aged 6–14 years: a cohort study

BACKGROUND: Paxlovid is recognized as an effective medication in preventing the progression of coronavirus disease of 2019 (COVID-19) to severe form in adults; however, its efficacy has remained unknown in pediatric cases. This study aimed to analyze the feasibility, safety, and efficacy of Paxlovid...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Gangfeng, Zhou, Jianguo, Zhu, Haitao, Chen, Yiwei, Lu, Yanming, Zhang, Ting, Yu, Hui, Wang, Libo, Xu, Hong, Wang, Zheng, Zhou, Wenhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263777/
https://www.ncbi.nlm.nih.gov/pubmed/35813342
http://dx.doi.org/10.21037/atm-22-2791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263777/
https://www.ncbi.nlm.nih.gov/pubmed/35813342
http://dx.doi.org/10.21037/atm-22-2791

Ejemplares similares